A breast cancer-associated mRNA originally cloned as a 475-bp partial cDNA from a library enriched for tumour cDNAs [Oncogene 16 (1998) 327] is expressed at high levels in breast and prostate cancer cells. Immunohistochemical analysis indicates that the protein is expressed in primary breast tumours. We used RT-PCR to generate a full-length 2852 nt mRNA sequence that includes the hypothetical open reading frame (ORF) for human RNF11. Our analysis shows that RNF11 encodes modular domains and motifs likely to interact with other proteins involved in oncogenesis. Chief among these are the RING-H2 finger domain that could facilitate the degradation of specific substrate(s) involved in oncogenesis and the PY motif which binds to WW-domain proteins, several of which are known to be E3 ubiquitin ligases. Our GST-pulldown and immunoprecipitation results indicate that RNF11 interacts with the E3 ligase AIP4 when coexpressed with RNF11 in mammalian cells.
Introduction
Malignancy at the molecular level is partly due to genetic mutations and deletions that result in the alteration of expression and function of various cellular genes. Progressive and cumulative changes in cellular DNA result in mutational activation of growth proliferative genes (e.g., proto-oncogenes) or inactivation of growth inhibitory genes (e.g., tumour suppressor genes) [2] [3] [4] . In the development of breast neoplasia, there are limited subsets of genes that will be specifically expressed at various stages. Only a certain number of these will be critical for the progression of malignancy, especially those associated with the metastatic spread of this disease. Once identified, such differentially expressed genes will be useful for diagnosis and for monitoring disease progression, for facilitating the molecular characterization of specific stages of tumour development as well as assisting in patient prognosis and selection of various treatment modalities. In addition, molecular definition of new genes involved in breast tumours will yield novel targets for gene therapy and for therapeutic intervention.
The RNF11 gene was originally cloned as sequence T2A10 from a library enriched for tumour cDNAs [1] . Its full-length cDNA was extended ''in silico'' using overlapping ESTs. We found it to be the human homologue of the mouse RING-H2 protein RNF11. The mRNA for human RNF11 is expressed at high levels in breast and prostate cancer cells and the RNF11 gene encodes modular domains and/or motifs known to interact with other proteins involved in oncogenesis and signal transduction. The RING-H2 finger domain could facilitate protein:protein interactions and the degradation of specific substrate(s) involved in the cell cycle and the PY motif which binds to WW-domains containing proteins, several of which are known to be HECT-type E3 ligases. Thus it is critical to identify the substrates of the E3 ligases and characterization of those substrates is crucial to understanding the potential role of RNF11 in oncogenesis and development of targeted inhibitors/inducers of their activity.
Methods

Culture of cell lines
Cancer cell lines were obtained from the American Type Culture Collection (Manassas, VA) and cultured as recommended. For transfections, HEK293T cells were maintained in high glucose DME medium (Gibco) containing 10% FBS without any antibiotics in 5% CO 2 atmosphere.
RNA extraction, Northern blots, and hybridization
Total RNA was extracted essentially according to Chomczynski et al. [5] . Seven to ten micrograms of total RNA collected from cell lines as described above was size-fractionated on a 1.2% agarose gel containing 2% formaldehyde and transferred to a nylon membrane by the capillary transfer method [6] . In addition, human multiple tissue Northern blots (Clontech) were purchased. Northern blot hybridizations were done overnight at 42 jC with 2 Â 10 6 cpm/ml of 32 P-radiolabeled random primer synthesized probe using the T2A10 cDNA as template (Amersham-Pharmacia Biotech.). The blots were washed at 60 jC with three changes of wash solution over 1 h and exposed to Kodak X-ray film after drying. Blots were stripped as described [7] , and rehybridized with either GAPDH or 32 P-radiolabeled h-actin cDNA probe.
Preparation of antibodies
Antibodies were raised in rabbits against a synthetic peptide sequence derived from the RNF11 C-terminal region and conjugated to keyhole limpet hemocyanin (KLH). Rabbit IgG polyclonal antibodies were purified on a peptide affinity column. 
Immunohistochemistry
The HistoStain SP Kit (rabbit, Zymed, San Francisco, CA) was used for immunohistochemical analysis of RNF11 protein in paraffin-embedded breast tissues. Immunoperoxidase staining was as described [8] with the modification that removal of endogenous peroxidase was followed by incubation in 0.1% trypsin (pH 7.4). RNF11 antibody (dil. 1:100, 40 Ag/ml) was added for 2 h at room temperature, negative control sections were incubated with pre-immune serum. The Elston and Ellis-modified [9] Bloom and Richardson method was used for histological grading of breast tumours.
Vectors
The RNF11-mPY construct is derived from the RT-PCR cloned coding region of RNF11 in PCMV-T2C-462 using the Quikchange Site Directed Mutagenesis Kit, (Stratagene) to substitute an alanine for the encoded tyrosine at position 40.
Transfection of 293-T cells
Asynchronously growing cells were plated in 100 mm dishes and given a fresh complete medium change 2 h prior to transfection. Two micrograms of tagged plasmid DNA was mixed with 250 mM CaCl 2 and 2 Â HBS (280 mM NaCl, 50 mM HEPES, 1.5 mM sodium phosphate) (pH 7.05) and incubated at room temperature for 15 min. The precipitate was then added to cells, which were incubated overnight prior to medium change as described [10] .
2.7. Expression of GST-fusion proteins and preparation of GST-sepharose beads BL21 bacteria transformed with expression vector constructs for GST-AIP4, GST-AIP4-WW1, or GST, were grown in 50 ml culture medium until OD (600) = 0.5-1. GST and GST fusion proteins were then induced by adding IPTG to a final concentration of 0.5 mM in each culture followed by incubation at 37 jC for 4 h. Bacteria were pelleted by 20 min of centrifugation 5000 rpm at 4 jC. Bacterial pellets were resuspended in 2 ml PBS (without Ca or Mg) then lysed by three cycles of freeze -thaw, 3 min in an EtOH-dry ice bath followed by 5 min at 37 jC, and sonication on ice. After the addition of 0.22 ml 10% Triton X-100 to the lysate, cell debris was removed by centrifugation at 12,000 Â g for 5 min at 4 jC. Cleared lysates were then incubated at 4 jC for 1 h with Glutathione-Sepharose 4B beads pre-washed in 3 Â 1 ml PBS + 1% Triton X-100, followed by two identical incubations with fresh wash buffer. After washing, beads were resuspended in 50 Al PBS + 1% Triton X-100 to form a 50% slurry.
GST-pulldown from eukaryotic cell lysates
A 50% slurry of the GST-beads or GST-AIP4 beads was incubated with 1 ml of transfected HEK293T, MCF7, or HTB26 cell lysates extracted from 90% confluent T75 flasks for 3 h at 4 jC with constant end-over-end rotation. The loaded beads were then washed with 1 ml NP40 lysis buffer, mixed with 25 Al 3 Â SDS-PAGE sample buffer and then boiled for 3 min.
Western blotting
Boiled samples were loaded onto 14% polyacrylamide gel and after electrophoresis the proteins were transferred onto Hybond-P membrane (Amersham). The resulting immunoblots were incubated overnight at 4 jC with antibodies in a total volume of 1 ml. The secondary antibody used in the immunoblot was a 1:5000 dilution of HRP-linked anti-rabbit IgG. Peptide competition was done by incubation of antibodies on ice in a total volume of 65 Al for 30 min with 3 Ag of the RNF11 antibody and 30 Ag of the RNF11 peptide immunogen used to induce the polyclonal serum.
Results
Structure and analysis of the RNF11 gene
In order to precisely define genes that are essential to the initiation and development of the sporadic form of breast cancer, we have isolated >1000 genes that may be activated or inactivated during progression of breast cancer. This was accomplished by subtractive hybridization and differential display methods using matched breast tumour and normal breast cell line RNAs [1, 11, 12] . Initial hybridization screening of 74 breast cancer-associated cDNAs arrayed on solid membrane supports revealed them to be differentially expressed between normal and malignant breast tissues using complex cDNA probes. Among other genes, we discovered a novel cDNA T2A10 which, after bioinformatic extension with GenBank EST sequences, was found to encode a consensus RING-H2 protein domain. We have also used RT-PCR cloning to confirm and extend the T2A10 sequence. Additional searches with this sequence revealed that a similar cDNA had been named RNF11. We have extended the existing RNF11 cDNA sequence (GenBank accession AB024703) by 330 nts at the 5V end and 482 nts at the 3V end of AB024703 (RNF11) [13] . Our analysis discovered a potential WW-domain binding PPPPY motif in the amino-terminal region in addition to the carboxy terminal RING-H2 domain.
We have located the RNF11 gene on chromosome 1 between nts 1852121 and 1815179 of Human Genome Project working segment NT_026948, where three exons encode the entire 2852 nt RNF11 mRNA sequence (Fig. 1) . Interestingly, the splice junctions occur immediately after the WW-binding motif and immediately before the RING- H2 domain and the exon between these regions contains two sequences corresponding to the consensus Y -x -x -hydrophobic motif indicative of potential SH2 domain binding sites ( Fig. 1 ) [14] . One cDNA clone, AL537945, does encode a sequence containing exon 1 joined to exon 3, that is, exactly lacking exon 2, and represents the possibility of a naturally occurring splice variant. At least 345 cDNAs can be clustered to form the Unigene RNF11 cDNA cluster, indicating that such a variant would be very rare. We also found a likely pseudogene encoding a single open reading frame (ORF) (GenBank XM_116772) that is contiguous and identical to a sequence within chromosome eight. In order to determine if the combination of a PY motif with a carboxy terminal RING-H2 domain is unique, we downloaded FASTA formatted sequences for amino acid sequences identified by the S.M.A.R.T database program as containing RING domains. Four hypothetical amino acid sequences representing two separate mRNAs for FLJ21343/ Ring finger protein 38 (RNF38) and KIAA1100 were found. RNF38 and KIAA1100 appear to be closely related to each other, and are encoded on separate regions of the human genome (c9, RNF38; c5, KIAA1100). Although RNF11 possesses consensus amino acids indicative of a PY motif and a RING-H2 domain, it does not otherwise share high sequence identity with these proteins (Fig. 2) .
Comparative genomics of RNF11
Our analysis of the extended RNF11 cDNA sequence has discovered that homologues of the full-length protein are encoded in the DNA of the zebrafish (Danio rerio), the pufferfish (Fugu rubripes), the African clawed frog (Xennopus laevis), and the Western clawed frog (Silurana tropicalis) as well as the fruitfly (Drosophila melanogaster) (Fig.  3) . No TIGR or Unigene clusters encode the full-length of RNF11 in frogs, fish, nematodes, or fruitflies. The ESTs we have used to deduce them are presented in Table 1 . The zebrafish amino acid sequence is eight amino acids shorter than other vertebrate RNF11 homologues, perhaps reflecting the evolutionary divergence of the zebrafish and from other vertebrates such as the pufferfish. Although unsupported by pufferfish ESTs, we have included the in silico spliced and translated protein sequences from ORFs encoded by genomic scaffold sequence CAAB01000455.1, and these ORFs correspond exactly to the three exons of the human RNF11 gene structure ( Fig. 3 and Table 1 ).
We found that the nematode RNF11 RING-H2 domain identified by Seki et al. [13] in GenBank entry Z35595 belongs to hypothetical protein CAA84635.1, derived from Caenorhabditis elegans cosmid C01G6.4. This genomic clone harbors five exons encoding a putative nematode homologue of RNF11 rather than the three exons that encode the vertebrate and fly genes. However, the final exon in both the human and nematode genes begins with the first amino acid of the RING-H2 domain. Other than 87% positive identity with the human amino acid sequence in the RING-H2 domain, there is no (default GenBank Blastp) significant similarity in the remainder of the nematode sequence. Although Seki et al. [13] did find a homologue of the RNF11 RING-H2 domain, they have not published the full-length homologue of RNF11 and the full-length sequence of nematode RNF11 remains elusive.
Both the fruitfly and the putative nematode amino acid sequences lack the PPPPY sequence found in vertebrate RNF11. The fruitfly gene structure is similar to that of vertebrates in that it has three exons, however exon 3 of the fruitfly includes all of the amino acid sequence corresponding to exons two and three of the human gene. Although the 87% sequence identity of the fruitfly RING domain with the human is similar in value to that of the nematode sequence, the fruitfly sequence is identical to human in the CIVP sequence at the beginning of the RING-H2 domain and the HIYH sequence between the two H residues diagnostic of the RING-H2 domain. In addition, the fruitfly protein maintains significant identity with the human protein outside the RING-H2 domain (Fig. 3) . It seems possible that the fruitfly sequence is a true homologue of the vertebrate RNF11, whereas the nematode gene is either highly divergent, not yet properly sequenced, or represents an unrecognized related gene family member.
Expression of RNF11 in human tumours and normal tissue
Human RNF11 RNA appears to be expressed at low levels in the lung, liver, kidney, pancreas, spleen, prostate, thymus, ovary, small intestine, colon, and peripheral blood lymphocytes, with stronger expression in the testes, heart, brain and placenta (Fig. 4A) . Highest expression of RNF11 is in the skeletal muscle. Three human prostate tumour cell lines and three human breast tumour cell lines were examined for RNF11 expression (Fig. 4B) . LnCAP prostate tumour cells have the strongest expression of the RNF11 transcript, with lower levels of RNF11 mRNA in the PC3 prostate tumour line and the MDA-MB-468 breast tumour cell line has the lowest expression of RNF11 mRNA (Fig.  4B) . HTB126 (also known as Hs578T) breast tumour cells, from which T2A10 was cloned, have the highest expression of the RNF11 transcript (Fig. 4B) .
RNF11 protein is expressed in breast tumour cell lines
RNF11 in the MCF7 breast cancer cell line was visualized by chemiluminescent detection using anti-RNF11 antibodies on an Western blot of proteins immunoprecipitated by anti-RNF11 antisera from MCF7 cell extracts. A band corresponding to RNF11 is seen only where anti-RNF11 antiserum was used and not when pre-immune serum was used for immunoprecipitation (Fig. 5) .
RNF11 protein is expressed in primary breast tumours
RNF11 protein expression in primary tumour and normal breast tissues was monitored by immunohistochemistry using affinity-purified anti-RNF11 polyclonal antibody as described in Methods. Our immunohistochemical results reveal that RNF11 is predominantly expressed in the cytoplasm of breast cancer cells. Staining of primary breast tissues revealed that anti-RNF11 antibody reacts with corresponding protein in cancer cells, but not with surrounding stroma and weakly if at all in normal breast epithelial cells (Fig. 6 ).
RNF11 interacts with the WW-domain E3 ligase AIP4
Interaction between human AIP4 and human RNF11 was also tested by transfection of HEK-293T cells with FLAG-RNF11 followed by GST-pulldown using recombinant GST-AIP4 protein. Total cell extracts contained detectable amounts of the recombinant FLAG-RNF11 as shown by Western blotting with anti-FLAG antibody after the GSTpulldown (Fig. 7A) . The anti-FLAG Western blot also shows that FLAG-RNF11 protein interacts with GST-AIP4 and not with GST.
Confirmation of the importance of the RNF11 PY motif in this interaction is provided by a similar GSTpulldown comparing mutant PY with wild-type Flag-RNF11 protein. (Fig. 7B) . The mutant RNF11-mPY has an alanine in place of the tyrosine in the PY motif (Fig.  1) , and this protein fails to show a band on the Flag Western blot after GST-pulldown with the AIP4 WW1-domain protein (Fig. 7B) .
In general, PY motifs interact with WW-domains, and this is consistent with our observation that recombinant GST-AIP4-WW1 protein pulls down the endogenous RNF11 protein from extracts of HTB26 cells (Fig. 7C ).
Discussion
The predicted amino acid sequence for the RNF11 cDNA contains a RING-H2 domain and a WW-domain binding motif, both of which mediate protein:protein interactions for proteins involved in signal transduction pathways and ubiquitin-mediated proteolysis (Fig. 1) [14, 15] . We were able to identify just two proteins that also contain both a PY motif and a RING-H2 domain. These hypothetical proteins, RNF38 and KIAA1100, are clearly related to each other (Fig. 2, upper) . The overall length of the proteins and the amino acid sequence of the RING-H2 domains indicate that they are not related to the RNF11 gene. The larger size of RNF38 and KIAA1100 suggests that they may have additional functions in the amino-terminal region. Nevertheless, RNF11, KIAA1100, and RNF38 may have similar functions due to the positioning of the PY motifs relatively close to the RING-H2 domain (Fig. 2, lower) . These hypothetical proteins have no published function, and although related to each other, they are clearly not related to RNF11. This leaves RNF11 as the only example yet of a RING-H2 domain protein that also possesses a functional PY motif.
Many RING-H2 domains are known to interact with E2 proteins that provide the ubiquitin moiety to E3 ligases. It is possible that RNF11 could mediate the association of one or more such E2s with E3 ligases that contain WW-domains such as, among others, the HECT-type ligases AIP4, NEDD4 and Smurf1.
The PPPPY sequence of RNF11 is identical to that of LMP2A, which has been shown to bind to WW-domain polypeptides derived from AIP4, an E3 ubiquitin ligase that mediates the ubiquitination and degradation of the breast tumour suppressor Syk [16, 17] . AIP4 is a HECT-type E3 ligase, a family of proteins that includes E6-AP, NEDD4, Smurf1, and Smurf2 and others [18] . Each is characterized by the HECT-domain, a 350-residue region located near the carboxy terminus containing an essential cysteine capable of forming thiol-ester intermediates with ubiquitin [19] . Although E6AP lacks a WW-domain, they exist in many other HECT domain proteins such as NEDD4, AIP4, Smurf 1 and Smurf2. Within the WW-domain, conserved tryptophans form a hydrophobic pocket capable of binding the prolinerich sequences known as WW-binding or PY motifs [20, 21] .
We found that GST-AIP4 binds RNF11 as shown by GST-pulldown of endogenous RNF11 from breast tumour cell lines, and of FLAG-tagged RNF11 from transfected HEK293T cells (Figs. 7A,C) [22] . This interaction is dependant upon the wild-type PY motif of RNF11, which interacts with WW-domain 1 of AIP4 (Fig. 7B ). It appears that WW-domain 1 of AIP4 is sufficient for interaction with endogenous RNF11 in HTB26 cells (Fig. 7C) .
Interactions of the RNF11 RING-H2 domain have not yet been tested. However, as with the PPPPY motif, it is highly conserved in all vertebrate genomes examined here. Unlike the WW-binding motif, much of the RING-H2 domain appears to be conserved in both the nematode and the fruitfly. The failure to find a highly conserved worm or insect ORF for RNF11 may simply be a product of incomplete genome and cDNA databases. On the other hand, the sudden evolutionary gain of a PPPPY motif and the high overall identity in all the vertebrates leads one to speculate that RNF11 has a function unique to the life of vertebrates. One possibility lies in the fact that the WW-domain containing HECT-type E3 ligase Smurf2 is an essential regulator of the TGFh receptor complex through its interactions with Smad proteins, however, no TGFh-like fly genes have yet been described. Although homologues of the Smad family proteins exist in the nematode and fruitfly, they act within BMP-like and activin-like receptors. It is expected that continued efforts to fully characterize all genes in most genomes will answer this question.
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